Purchase Order 75H71024P01551
- Not listed
- This is a $92,455.35 Firm Fixed Price delivery order awarded by the Indian Health Service to Becton, Dickinson and Company (BD) on September 1, 2018. The order, which has an ultimate completion date of August 31, 2023, is placed against BD's GSA Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. The contract does not have a set-aside designation. BD, through its IDS division operating as BD Diagnostic Systems, is a leading manufacturer of medical supplies, devices, laboratory...
- This is a delivery order issued under a Blanket Purchase Agreement (BPA) by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services. The contract was awarded to Becton, Dickinson and Company (BD), a leading manufacturer of medical devices, instruments, and diagnostic products, for the delivery of lab supplies and equipment. The award has a ceiling value of $48,697.43 and a completion date of November 25, 2024. BD provides a wide range of critical...
- This firm fixed-price purchase order was awarded by the National Cancer Institute, part of the Department of Health and Human Services, to Becton, Dickinson and Company's IDS division operating as BD Diagnostic Systems. The $314,036 contract, which has no set-aside designation, is for the provision of medical supplies, devices, laboratory equipment, and diagnostic products. Becton, Dickinson is a leading global medical technology company that has received over $500 million in prime federal...
- This federal contract award is for the delivery of specialized medical supplies and services to the U.S. government by Becton, Dickinson and Company (BD), a global medical technology manufacturer. The $1,786.65 fixed-price delivery order was awarded by the Medical Supply Chain, a defense agency, with an ultimate completion date of June 10, 2025. The contract does not have a set-aside designation, indicating BD competed effectively in the open federal marketplace. BD, through its IDS division,...
- This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian agency of the U.S. government, to Becton, Dickinson and Company's IDS division, operating as BD Diagnostic Systems. The $89,768.78 contract is for BD to provide testing supplies and reagent kits for the BD Phoenix M50 Microbiology System and BD FX Automated Blood Culture System to the IHS. This contract does not have a set-aside designation. Becton, Dickinson and Company is a leading global medical...
- This is a federal contract award from the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for CCHCF LABORATORY BACTEC FX AND NUC COMPUTER SERVICES. The contract has a ceiling value of $34,966.44 and is a firm fixed-price purchase order with a period of performance through June 2, 2026. The contract was awarded on June 3, 2025 without a set-aside designation, indicating BD's ability to compete for the...
- This is a $19,956.48 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) through a total small business set-aside. The contract is for the provision of medical supplies, devices, laboratory equipment, and diagnostic products by BD's IDS division, operating as BD Diagnostic Systems, to support government healthcare and biomedical...
- The federal contract award was made by the National Institute on Drug Abuse, a component of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company's IDS division, operating as BD Diagnostic Systems. The $75,816 firm fixed-price purchase order is for the delivery of unspecified medical supplies and equipment. The contract has no set-aside designation. Becton, Dickinson and Company is a major manufacturer and supplier of medical devices, instruments, reagents, and...
- This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS) to Becton, Dickinson and Company (BD) for $128,500.00. The contract is for the purchase of required testing supplies and reagent kits for the BD Phoenix M50 Microbiology System and BD FX Automated Blood Culture System. The contract has an ultimate completion date of August 31, 2025. This award is not designated as a set-aside contract. BD is a global medical technology company that specializes in manufacturing...
- This contract award to Becton, Dickinson and Company (BD), with a ceiling value of $144,662.17, is for the provision of laboratory services to the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services. The contract is a delivery order against BD's existing General Services Administration (GSA) schedule contract for in vitro diagnostics, reagents, and test kits. The period of performance runs from April 1, 2021 to March 31, 2022, with an ultimate...
This $24,217 firm fixed-price purchase order was awarded by the Indian Health Service to Becton, Dickinson and Company's IDS division, operating as BD Diagnostic Systems, to provide clinical laboratory services. The period of performance is from April 1, 2024 to March 31, 2025, with a completion date of October 31, 2024. Becton, Dickinson is a leading global medical technology company that has received over $500 million in prime federal contract awards to provide critical medical equipment, supplies, and testing services to various agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services. The company holds several Indefinite Delivery Vehicles and Blanket Purchase Agreements with the federal government, allowing for streamlined ordering of products and services. This specific award is not associated with a set-aside program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 9/20/24 |